Regrowing limbs, a cure for AML found at the bottom of the ocean and software for data centres to use 25% less energy are all more science than fiction thanks to these 10 spinouts.
Cancer survival rates have increased dramatically over the past century, but immunotherapies are not a holy grail — yet.
A cure for diabetes, food made from CO2 and a wound dressing that kills superbugs are all a step closer to reality thanks to these 10 spinouts.
How do you stop AI from being racist? What if you could diagnose autism at birth using a single strand of hair? Here are 10 spinouts doing this and more.
Today, 1.3 million people die each year because of antimicrobial resistance, a figure that could increase to 10 million by 2050 — Strathclyde’s Microplate Dx hopes to prevent that.
Enzymes to infinitely recycle plastic, a way to make green ammonia and an app to detect early Alzheimer's are among this month's noteworthy technologies.
Cures for HIV and blurred vision and using cosmic rays to monitor nuclear waste drums are on our list of recent promising university spinouts.
CasInvent Pharma’s approach is aimed at three forms of cancer rather than just one, with leukaemia, lymphoma and solid tumours all in its sights.
Non-recyclable plastics making asphalt more sustainable and a vaccine to save the honeybee are just two of 10 inventions that caught our eye.
About half of all vaccines are wasted due to challenges surrounding cold chain logistics, so EnsiliTech aims to remove the need for cold storage.
Spinouts working on ketamine-based therapeutics, regenerative medicines for dogs and better sleep are among those that caught our eye this month.
These are the spinouts that caught our eye over the past month. Here's why they should be on your radar, too.
Launched just a year ago to build on work at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has now closed an oversubscribed series C round.
Yamaha Motor's sophomore Exploratory Fund brings the amount it has committed to corporate VC to $300m in the past five years.
CVC veteran Eric Steager has left Touchdown Ventures and joined Purdue University subsidiary Purdue Ventures as managing director.
What's going to happen to healthcare startup funding this year? Will the IPO market recover? And what kinds of technologies are on the up? We asked some leading CVCs for their view.
The $275m round, the largest series B for three months, featured several pharmaceutical companies and is part of a thriving environment for gene therapy startups.
Global University Venturing is a quarterly magazine and website written for and about universities taking stakes in the spinout companies of staff and students. We help universities to share best practice and to connect with each other, with investors and with other useful parties in the innovation ecosystem. Our aim is to help improve the processes of bringing innovations from academia to the market and facilitate their integration into the business ecosystem.
